FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/05/066936 [Registered on: 07/05/2024] Trial Registered Prospectively
Last Modified On: 05/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Homoeopathic treatment for emotional dysregulation of women with chronic pelvic pain from gynaecological disorders. 
Scientific Title of Study   Role of individualized homoeopathic medicine in emotional dysregulation of women with chronic pelvic pain from gynaecological disorders- a single arm pre-post clinical study. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Likhi Prasannan 
Designation  Postgraduate Trainee 
Affiliation  National Institute of Homoeopathy. 
Address  OPD room no: 14 & 31, Department of Organon of Medicine. National Institute of Homoeopathy, GE Block, Sector - III, Salt lake, Kolkata - 700106

Kolkata
WEST BENGAL
700106
India 
Phone  9496355249  
Fax    
Email  mail2likhi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr Ompriya Mishra 
Designation  Professor  
Affiliation  National Institute of Homoeopathy. 
Address  OPD room no: 31, Department of Obstetrics and Gynaecology, National Institute of Homoeopathy, GE Block, Sector - III, Salt lake, Kolkata - 700106

Kolkata
WEST BENGAL
700106
India 
Phone  8240359414  
Fax    
Email  drompriyanih@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr Ompriya Mishra 
Designation  Professor  
Affiliation  National Institute of Homoeopathy. 
Address  OPD room no: 31, Department of Obstetrics and Gynaecology, National Institute of Homoeopathy, GE Block, Sector - III, Salt lake, Kolkata - 700106

Kolkata
WEST BENGAL
700106
India 
Phone  8240359414  
Fax    
Email  drompriyanih@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Homoeopathy, GE Block, Sector- III, Salt lake, Kolkata- 700106  
 
Primary Sponsor  
Name  National Institute of Homoeopathy. 
Address  GE Block, Sector- III, Salt lake, Kolkata- 700106  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Likhi Prasannan  National Institute of Homoeopathy  OPD no: 14 and 31, Department Of Organon of Medicine, GE Block, Sector – III, Salt Lake, Kolkata – 700106
Kolkata
WEST BENGAL 
9496355249

mail2likhi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethical committee of National Institute of Homoeopathy  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: R102||Pelvic and perineal pain,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualized Homoeopathic medicine in suitable potency.  All patients will be prescribed individualized homoeopathic medicine after detailed case taking in accordance with the directions given by Dr. C.F.S Hahnemann in ‘Organon of Medicine’6th Edition. Indicated individualized homoeopathic medicine in suitable potency will be prescribed. Dose and frequency of medicine will be decided as per the homoeopathic principles. Follow up will be done monthly till 6 months from the baseline. 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  1 Patients with chronic pelvic pain having clinical symptoms of gynaecological
disorders, with or without findings in ultrasonography abdomen and pelvis.
2. Female patients of 18- 50 years of age
3. Patients with chronic pelvic pain showing any findings of gynaecological disorders in
ultrasonography abdomen and pelvis.
4. Patients who score 19 or below in cognitive reappraisal and 7 or above for expressive
suppression in Emotion Regulation Questionnaire (ERQ) 32
5. Patients who can read/ understand either English, Hindi, Bengali.
6. Patients who are willing to participate in study and giving written informed consent. 
 
ExclusionCriteria 
Details  1.Patient suffering from pelvic pain only during menstrual cycle.
2. Patients who have attained menopause
3. Patients suffering from chronic pelvic pain due to urological, gastrointestinal,
musculoskeletal or neurological disorders.
4. Patients who are pregnant, lactating, taking OCP or done hysterectomy.
5. Patients who are taking medications for any other chronic disease.
6. Patients who are diagnosed with life threatening diseases, systemic illness, immunocompromised states, psychiatric illness and malignancy.
7. Substance abuse and/or dependence. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Difficulty in Emotion Regulation Scale. (DERS)  Baseline and 6th month. 
 
Secondary Outcome  
Outcome  TimePoints 
Functional Pelvic Pain Scale (FPPS)  Baseline and 6th month 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   20/05/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Chronic Pelvic Pain (CPP) is persistent pelvic pain for at least 6 months and is severe enough to cause functional disability and lead to medical care. CPP cannot be viewed as single entity, rather a constellation of predisposing factors and altered mechanism, is an important presenting symptom that can arise from a diverse group of disorders. The incidence of CPP associated with gynaecological disorders are probably in excess. Gynaecological comorbidities are seen in an estimated twenty percent of patients with chronic pelvic pain. Specific gynaecological conditions that can cause CPP include endometriosis, pelvic adhesions, chronic pelvic inflammatory diseases, ovarian remnant, pelvic congestion syndrome and adenomyosis. The prevalence of CPP is approximately between four to sixteen percent of women. Up to 24% of women globally suffer from CPP. Emotion regulation plays a vital role in maintaining psychological well- being and significant implications for both physical and mental health. Research proves that by effectively recognizing, understanding and managing human emotions helps in overall well - being of the individuals extending its benefits to physiological process and normalization of pelvic and hormonal physiology. The study is focused on women with CPP from gynaecological disorders, due to amalgamation of emotions and hormonal changes that is clearly evident in monthly menstrual cycle of women. These disturbances show up as menstrual irregularities, severe premenstrual syndrome, leucorrhea and mood swings. An Individualized homoeopathic medicine based on totality of symptoms which include patient’s mental and physical sphere works holistically improving the mental sphere and improve physical signs and symptoms that are evident in homoeopathic cures. A Prospective, Nonrandomized, Open label, Single arm, Pre- Post Clinical Study with a sample size of 40 female chronic pelvic pain patients from gynaecological disorders satisfying inclusion and exclusion criteria shall be enrolled for the study. CPP patients suffering from gynaecological disorders who score 19 or below in cognitive reappraisal and 7 or above in expressive suppression in Emotion Regulation Questionnaire (ERQ) will be only enrolled for the study. The primary objective is to determine the changes in Difficulty in Emotion regulation Scale (DERS) at the baseline and after 6 months of intervention with Individualized homoeopathic medicine in suitable potency in accordance with the directions in Organon of Medicine (6th edition).  Secondary objective is to determine the changes in intensity of pain in Functional Pelvic Pain Scale (FPPS) at the baseline and after 6 months of intervention. Ultrasound assessment of the abdomen and pelvis would be used as a secondary outcome tool for diagnosing gynaecological  disorders. The descriptive data will be recorded in terms of absolute values, percentage etc. as appropriate. The score obtained by the patients will be compared and result analyzed as per appropriate statistical methods and inference will be done thereafter. The result will be published in scientific journals. 
Close